Pulmicort (budesonide) is one of the world’s leading asthma medicines. It is an inhaled anti-inflammatory glucocorticosteroid for initiation and maintenance treatment of bronchial asthma in infants, children and adults. In some countries Pulmicort is also indicated for the treatment of Chronic Obstructive Pulmonary Disease (COPD).

Pulmicort can be prescribed as once- or twice-daily therapy depending on disease severity. Pulmicort is available in a range of formulations: Pulmicort Turbuhaler (dry powder inhaler), Pulmicort pMDI (pressurised metered dose inhaler), and Pulmicort Respules (suspension for nebulisation). Trade names and availability of formulations may differ between countries.